Cormorant Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.4M | Sell |
|
|||||
|
2025
Q1 | $29.2M | Sell |
|
|||||
|
2024
Q4 | $27.5M | Sell |
|
|||||
|
2024
Q3 | $35.9M | Hold |
|
|||||
|
2024
Q2 | $32.2M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $24.4M | Buy |
|
|||||
|
2023
Q1 | $18.5M | Sell |
|
|||||
|
2022
Q4 | $25.1M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $7.85M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $11.3M | Hold |
|
|||||
|
2020
Q4 | $16.3M | Sell |
|
|||||
|
2020
Q3 | $17.8M | Sell |
|
|||||
|
2020
Q2 | $28.8M | Sell |
|
|||||
|
2020
Q1 | $29.4M | Sell |
|
|||||
|
2019
Q4 | $62M | Buy |
|